Monday, 7 April 2025 »  Login
in
»
I am at

Genome Valley Phase-II In 300 Acres Soon: CM

Revanth Reddy made the announcement at the inauguration of the healthcare and life sciences conference BioAsia's 2024 edition at Hitex.
Hyderabad | 27th February 2024
Telangana Chief Minister Revanth Reddy today announced that the State government would establish a second phase of the Hyderabad Genome Valley soon.

The CM was speaking after inaugurating the healthcare and life sciences conference BioAsia's 2024 edition at Hitex. On the occasion, he congratulated Nobel Laureate Professor Greg L Semenza for being selected for the Genome Valley Excellence Award this year.

Addressing the conference, Reddy said, "The Genome Valley will be established in three hundred acres with an investment of Rs 2,000 crore. The process of setting up ten pharma villages with an investment of Rs 1 lakh crore has already begun. The pharma villages will be established in greenfield pharma sectors in Vikarabad, Medak and Nalgonda districts. This will open up enormous opportunities for aspiring entrepreneurs. The new facility will provide 5 lakh jobs. The greenfield facility will also be very convenient for all the entrepreneurs of the world as it is located very close to the Hyderabad international airport."

He also said that the BioAsia conference had become crucial amid rising health concerns around the world after the Covid pandemic.

The CM added that Hyderabad as the capital of bioscience had created a confidence in all of mankind today, and that one of every three vaccines used in the world was being produced in Hyderabad. He said that his government was committed to developing Hyderabad, which was already an IT and biosciences capital. Many international and domestic organisations had consolidated their presences here without any hurdles, he claimed.

"My government is also giving top priority to the MSME sector which creates a bridge between small start-ups and big corporates," Reddy said.

The CM also said that Telangana had already received huge investments of Rs 40,232 crore in the recently held World Economic Forum at Davos, and that his government was ready to fulfill the dreams of investors and entrepreneurs.

He also welcomed Takeda entering into an agreement with Biological E to produce 5 crore doses of vaccines annually.

"We are creating confidence in the world that Hyderabad is ready to produce vaccines," Reddy said.

Minister for IT and Industries Sridhar Babu was also present in the program.
filed in:  Telangana, BioAsia, Events & Exhibitions, Revanth Reddy, Biotech, Pharma Industry, Industry & Business
COMMENTS
Be the first to comment on Genome Valley Phase-II In 300 Acres Soon: CM! Just use the simple form below.
LEAVE A COMMENT
fullhyd.com has 700,000+ monthly visits. Tell Hyderabad what you feel about Genome Valley Phase-II In 300 Acres Soon: CM!
[no link to your name will appear, overriding global settings]
To preserve integrity, fullhyd.com allows ratings/comments only with a valid email. Your comments will be accepted once you give your email, and will be deleted if the email is not authenticated within 24 hours.
My name:

Dissatisfied with the results? Report a problem or error, or add a listing.
ADVERTISEMENT
SHOUTBOX!
{{todo.name}}
{{todo.date}}
[
]
{{ todo.summary }}... expand »
{{ todo.text }} « collapse
First  |  Prev  |   1   2  3  {{current_page-1}}  {{current_page}}  {{current_page+1}}  {{last_page-2}}  {{last_page-1}}  {{last_page}}   |  Next  |  Last
{{todos[0].name}}

{{todos[0].text}}

ADVERTISEMENT
This page was tagged for
hyderabad February 2024 News
Telangana news
BioAsia updates
Follow fullhyd.com on
Copyright © 2023 LRR Technologies (Hyderabad) Pvt Ltd. All rights reserved. fullhyd and fullhyderabad are registered trademarks of LRR Technologies (Hyderabad) Pvt Ltd. The textual, graphic, audio and audiovisual material in this site is protected by copyright law. You may not copy, distribute or use this material except as necessary for your personal, non-commercial use. Any trademarks are the properties of their respective owners.